Alzheimer Dis Assoc Disord

1. WANG T, Guo Z, Du Y, Xiong M, et al
   Effects of Noninvasive Brain Stimulation (NIBS) on Cognitive Impairment in Mild Cognitive Impairment and Alzheimer Disease: A Meta-analysis.
   Alzheimer Dis Assoc Disord. 2021;35:278-288.
   

   >> Share

   
   

   
   Alzheimers Dement

2. WANG Q, Davis PB, Gurney ME, Xu R, et al
   COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.
   Alzheimers Dement. 2021;17:1297-1306.
   

   >> Share

   
   

   
   Am J Geriatr Psychiatry

3. TALASLAHTI T, Ginters M, Kautiainen H, Vataja R, et al
   Criminal Behavior in the Four Years Preceding Diagnosis of Neurocognitive Disorder: A Nationwide Register Study in Finland.
   Am J Geriatr Psychiatry. 2021;29:657-665.
   

   >> Share

   
   

   
   Brain

4. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
   Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
   Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
   

   >> Share

   
   
5. KHAN AR, Ottoy J, Goubran M
   Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
   Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
   

   >> Share

   
   

   
   Curr Alzheimer Res

6. JANOUTOVA J, Kovalova M, Machaczka O, Ambroz P, et al
   Risk Factors for Alzheimer's Disease: An Epidemiological Study.
   Curr Alzheimer Res. 2021 Aug 20. pii: CAR-EPUB-117419.
   

   >> Share

   
   
7. PATEL P, Masurkar AV
   The Relationship of Anxiety with Alzheimer's Disease: A Narrative Review.
   Curr Alzheimer Res. 2021 Aug 22. pii: CAR-EPUB-117429.
   

   >> Share

   
   

   
   J Alzheimers Dis

8. QURESHI ZP, Thiel E, Nelson J, Khandker R, et al
   Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
   J Alzheimers Dis. 2021 Aug 20. pii: JAD210713. doi: 10.3233/JAD-210713.
   

   >> Share

   
   
9. WANG H, Xu Y, Ren R, Yao F, et al
   Ambulatory Blood Pressure Characteristics of Patients with Alzheimer's Disease: A Multicenter Study from China.
   J Alzheimers Dis. 2021 Aug 16. pii: JAD210679. doi: 10.3233/JAD-210679.
   

   >> Share

   
   
10. CIOFFI F, Ibrahim Adam RH, Bansal R, Broersen K, et al
    A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD210497. doi: 10.3233/JAD-210497.
    

    >> Share

    
    
11. YANG HJ, Lee S, Koh MJ, Lee HK, et al
    The Association of White Matter Hyperintensities with Frailty in Patients with Very Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210494. doi: 10.3233/JAD-210494.
    

    >> Share

    
    
12. TOK S, Ahnaou A, Drinkenburg W
    Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210397. doi: 10.3233/JAD-210397.
    

    >> Share

    
    
13. GE F, Zhu D, Tian M, Shi J, et al
    The Role of Thyroid Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210339. doi: 10.3233/JAD-210339.
    

    >> Share

    
    
14. WIMO A, Belger M, Bon J, Jessen F, et al
    A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210303. doi: 10.3233/JAD-210303.
    

    >> Share

    
    
15. BARTHOLD D, Gibbons LE, Marcum ZA, Gray SL, et al
    Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.
    J Alzheimers Dis. 2021 Aug 14. pii: JAD210059. doi: 10.3233/JAD-210059.
    

    >> Share

    
    
16. TOFIQ A, Zetterberg H, Blennow K, Basun H, et al
    Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210007. doi: 10.3233/JAD-210007.
    

    >> Share

    
    
17. ZANGROSSI A, Montemurro S, Altoe G, Mondini S, et al
    Heterogeneity and Factorial Structure in Alzheimer's Disease: A Cognitive Perspective.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210719. doi: 10.3233/JAD-210719.
    

    >> Share

    
    
18. MOMMAERTS K, Willemse EAJ, Marchese M, Larue C, et al
    A Cystatin C Cleavage ELISA Assay as a Quality Control Tool for Determining Sub-Optimal Storage Conditions of Cerebrospinal Fluid Samples in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210741. doi: 10.3233/JAD-210741.
    

    >> Share

    
    
19. ROBAKIS NK
    On the Nomenclature of the Alzheimer's Disease Amyloid and Its Precursor1.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD215138. doi: 10.3233/JAD-215138.
    

    >> Share

    
    

    
    J Biol Chem

20. LEE YH, Im E, Hyun M, Park J, et al
    Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation.
    J Biol Chem. 2021;296:100245.
    

    >> Share

    
    
21. TALESKI G, Schuhmacher D, Su H, Sontag JM, et al
    Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis, and APP regulation.
    J Biol Chem. 2021;296:100237.
    

    >> Share

    
    
22. REYES-RUIZ JM, Nakajima R, Baghallab I, Goldschmidt L, et al
    An "epitomic" analysis of the specificity of conformation-dependent, anti-Ass amyloid monoclonal antibodies.
    J Biol Chem. 2021;296:100168.
    

    >> Share

    
    
23. SHIELDS LY, Li H, Nguyen K, Kim H, et al
    Mitochondrial fission is a critical modulator of mutant APP-induced neural toxicity.
    J Biol Chem. 2021;296:100469.
    

    >> Share

    
    

    
    J Neurochem

24. CORTES-GOMEZ MA, Llorens-Alvarez E, Alom J, Del Ser T, et al
    Tau phosphorylation by glycogen synthase kinase 3beta modulates enzyme acetylcholinesterase expression.
    J Neurochem. 2021;157:2091-2105.
    

    >> Share

    
    

    
    J Neurosci

25. WU M, Liu CZ, Barrall EA, Rissman RA, et al
    Unbalanced regulation of alpha7 nAChRs by Ly6h and NACHO contributes to neurotoxicity in Alzheimer's disease.
    J Neurosci. 2021 Aug 26. pii: JNEUROSCI.0494-21.2021.
    

    >> Share

    
    

    
    JAMA

26. RUBIN R
    CMS Considers Controversial Alzheimer Drug Coverage.
    JAMA. 2021;326:690.
    

    >> Share

    
    

    
    Lancet Neurol

27. PARNETTI L, Filippo MD, Gaetani L
    A blood test for Alzheimer's disease: a step forward.
    Lancet Neurol. 2021;20:691-693.
    

    >> Share

    
    
28. THIJSSEN EH, La Joie R, Strom A, Fonseca C, et al
    Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Lancet Neurol. 2021;20:739-752.
    

    >> Share

    
    

    
    Neurobiol Aging

29. FLEMING V, Piro-Gambetti B, Patrick A, Zammit M, et al
    Physical activity and cognitive and imaging biomarkers of Alzheimer's disease in down syndrome.
    Neurobiol Aging. 2021;107:118-127.
    

    >> Share

    
    
30. WISSE LEM, Ungrady MB, Ittyerah R, Lim SA, et al
    Cross-sectional and longitudinal medial temporal lobe subregional atrophy patterns in semantic variant primary progressive aphasia.
    Neurobiol Aging. 2021;98:231-241.
    

    >> Share

    
    
31. GUO C, Zhang Y, Nie Q, Cao D, et al
    SQSTM1/ p62 oligomerization contributes to Abeta-induced inhibition of Nrf2 signaling.
    Neurobiol Aging. 2021;98:10-20.
    

    >> Share

    
    

    
    Neurology

32. SANDERS AE
    A Century-Old Problem: Cognition and Neuropsychiatric Symptoms in Alzheimer Disease.
    Neurology. 2021 Aug 20. pii: WNL.0000000000012616.
    

    >> Share

    
    

    
    Neurosci Lett

33. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    

    >> Share

    
    
34. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    

    >> Share

    
    

    
    PLoS One

35. LEE SH, Chen YH, Chien CC, Yan YH, et al
    Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model.
    PLoS One. 2021;16:e0254587.
    

    >> Share

    
    
36. SAKUTA S, Hashimoto M, Ikeda M, Koyama A, et al
    Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?
    PLoS One. 2021;16:e0247184.
    

    >> Share

    
    

    
    Science

37. SERVICK K
    Alzheimer's drug approval spotlights blood tests.
    Science. 2021;373:373-374.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share